The global Herceptin (Trastuzumab) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Herceptin (Trastuzumab) is a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor from attaching to Her2. Herceptin also stimulates the body's own immune cells to destroy cancer cells. Clinically, it is mainly used for metastatic breast cancer with excessive expression of her-2. Monotherapy may be used for metastatic breast cancer that has received one or more chemotherapy regimens; It can be combined with paclitaxel to treat metastatic breast cancer without chemotherapy.
This report includes an overview of the development of the Herceptin (Trastuzumab) industry chain, the market status of Hospital (Breast Cancer, Stomach Cancer), Medical Center (Breast Cancer, Stomach Cancer), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Herceptin (Trastuzumab).
Regionally, the report analyzes the Herceptin (Trastuzumab) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Herceptin (Trastuzumab) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Herceptin (Trastuzumab) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Herceptin (Trastuzumab) industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Breast Cancer, Stomach Cancer).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Herceptin (Trastuzumab) market.
Regional Analysis: The report involves examining the Herceptin (Trastuzumab) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Herceptin (Trastuzumab) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Herceptin (Trastuzumab):
Company Analysis: Report covers individual Herceptin (Trastuzumab) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Herceptin (Trastuzumab) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Medical Center).
Technology Analysis: Report covers specific technologies relevant to Herceptin (Trastuzumab). It assesses the current state, advancements, and potential future developments in Herceptin (Trastuzumab) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Herceptin (Trastuzumab) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Herceptin (Trastuzumab) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
麻豆原创 segment by Type
Breast Cancer
Stomach Cancer
Others
麻豆原创 segment by Application
Hospital
Medical Center
Major players covered
Roche Diagnostics
Genentech
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Amgen
Samsung Bioepis
Merck
Mylan
Teva Pharmaceutical
Mundipharma
Mabion
AryoGen Biopharma
Genor Biopharma
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Herceptin (Trastuzumab) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Herceptin (Trastuzumab), with price, sales, revenue and global market share of Herceptin (Trastuzumab) from 2019 to 2024.
Chapter 3, the Herceptin (Trastuzumab) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Herceptin (Trastuzumab) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Herceptin (Trastuzumab) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Herceptin (Trastuzumab).
Chapter 14 and 15, to describe Herceptin (Trastuzumab) sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Herceptin (Trastuzumab)
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Herceptin (Trastuzumab) Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Breast Cancer
1.3.3 Stomach Cancer
1.3.4 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Herceptin (Trastuzumab) Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Medical Center
1.5 Global Herceptin (Trastuzumab) 麻豆原创 Size & Forecast
1.5.1 Global Herceptin (Trastuzumab) Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Herceptin (Trastuzumab) Sales Quantity (2019-2030)
1.5.3 Global Herceptin (Trastuzumab) Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Roche Diagnostics
2.1.1 Roche Diagnostics Details
2.1.2 Roche Diagnostics Major Business
2.1.3 Roche Diagnostics Herceptin (Trastuzumab) Product and Services
2.1.4 Roche Diagnostics Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Roche Diagnostics Recent Developments/Updates
2.2 Genentech
2.2.1 Genentech Details
2.2.2 Genentech Major Business
2.2.3 Genentech Herceptin (Trastuzumab) Product and Services
2.2.4 Genentech Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Genentech Recent Developments/Updates
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Herceptin (Trastuzumab) Product and Services
2.3.4 Novartis AG Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Novartis AG Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Herceptin (Trastuzumab) Product and Services
2.4.4 Pfizer Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 Abnova Corporation
2.5.1 Abnova Corporation Details
2.5.2 Abnova Corporation Major Business
2.5.3 Abnova Corporation Herceptin (Trastuzumab) Product and Services
2.5.4 Abnova Corporation Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Abnova Corporation Recent Developments/Updates
2.6 InvivoGen
2.6.1 InvivoGen Details
2.6.2 InvivoGen Major Business
2.6.3 InvivoGen Herceptin (Trastuzumab) Product and Services
2.6.4 InvivoGen Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 InvivoGen Recent Developments/Updates
2.7 Celltrion
2.7.1 Celltrion Details
2.7.2 Celltrion Major Business
2.7.3 Celltrion Herceptin (Trastuzumab) Product and Services
2.7.4 Celltrion Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Celltrion Recent Developments/Updates
2.8 Biocon Limited
2.8.1 Biocon Limited Details
2.8.2 Biocon Limited Major Business
2.8.3 Biocon Limited Herceptin (Trastuzumab) Product and Services
2.8.4 Biocon Limited Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Biocon Limited Recent Developments/Updates
2.9 Bio-Techne
2.9.1 Bio-Techne Details
2.9.2 Bio-Techne Major Business
2.9.3 Bio-Techne Herceptin (Trastuzumab) Product and Services
2.9.4 Bio-Techne Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Bio-Techne Recent Developments/Updates
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business
2.10.3 Amgen Herceptin (Trastuzumab) Product and Services
2.10.4 Amgen Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Amgen Recent Developments/Updates
2.11 Samsung Bioepis
2.11.1 Samsung Bioepis Details
2.11.2 Samsung Bioepis Major Business
2.11.3 Samsung Bioepis Herceptin (Trastuzumab) Product and Services
2.11.4 Samsung Bioepis Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Samsung Bioepis Recent Developments/Updates
2.12 Merck
2.12.1 Merck Details
2.12.2 Merck Major Business
2.12.3 Merck Herceptin (Trastuzumab) Product and Services
2.12.4 Merck Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Merck Recent Developments/Updates
2.13 Mylan
2.13.1 Mylan Details
2.13.2 Mylan Major Business
2.13.3 Mylan Herceptin (Trastuzumab) Product and Services
2.13.4 Mylan Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Mylan Recent Developments/Updates
2.14 Teva Pharmaceutical
2.14.1 Teva Pharmaceutical Details
2.14.2 Teva Pharmaceutical Major Business
2.14.3 Teva Pharmaceutical Herceptin (Trastuzumab) Product and Services
2.14.4 Teva Pharmaceutical Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Teva Pharmaceutical Recent Developments/Updates
2.15 Mundipharma
2.15.1 Mundipharma Details
2.15.2 Mundipharma Major Business
2.15.3 Mundipharma Herceptin (Trastuzumab) Product and Services
2.15.4 Mundipharma Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 Mundipharma Recent Developments/Updates
2.16 Mabion
2.16.1 Mabion Details
2.16.2 Mabion Major Business
2.16.3 Mabion Herceptin (Trastuzumab) Product and Services
2.16.4 Mabion Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 Mabion Recent Developments/Updates
2.17 AryoGen Biopharma
2.17.1 AryoGen Biopharma Details
2.17.2 AryoGen Biopharma Major Business
2.17.3 AryoGen Biopharma Herceptin (Trastuzumab) Product and Services
2.17.4 AryoGen Biopharma Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 AryoGen Biopharma Recent Developments/Updates
2.18 Genor Biopharma
2.18.1 Genor Biopharma Details
2.18.2 Genor Biopharma Major Business
2.18.3 Genor Biopharma Herceptin (Trastuzumab) Product and Services
2.18.4 Genor Biopharma Herceptin (Trastuzumab) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.18.5 Genor Biopharma Recent Developments/Updates
3 Competitive Environment: Herceptin (Trastuzumab) by Manufacturer
3.1 Global Herceptin (Trastuzumab) Sales Quantity by Manufacturer (2019-2024)
3.2 Global Herceptin (Trastuzumab) Revenue by Manufacturer (2019-2024)
3.3 Global Herceptin (Trastuzumab) Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Herceptin (Trastuzumab) by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Herceptin (Trastuzumab) Manufacturer 麻豆原创 Share in 2023
3.4.2 Top 6 Herceptin (Trastuzumab) Manufacturer 麻豆原创 Share in 2023
3.5 Herceptin (Trastuzumab) 麻豆原创: Overall Company Footprint Analysis
3.5.1 Herceptin (Trastuzumab) 麻豆原创: Region Footprint
3.5.2 Herceptin (Trastuzumab) 麻豆原创: Company Product Type Footprint
3.5.3 Herceptin (Trastuzumab) 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Herceptin (Trastuzumab) 麻豆原创 Size by Region
4.1.1 Global Herceptin (Trastuzumab) Sales Quantity by Region (2019-2030)
4.1.2 Global Herceptin (Trastuzumab) Consumption Value by Region (2019-2030)
4.1.3 Global Herceptin (Trastuzumab) Average Price by Region (2019-2030)
4.2 North America Herceptin (Trastuzumab) Consumption Value (2019-2030)
4.3 Europe Herceptin (Trastuzumab) Consumption Value (2019-2030)
4.4 Asia-Pacific Herceptin (Trastuzumab) Consumption Value (2019-2030)
4.5 South America Herceptin (Trastuzumab) Consumption Value (2019-2030)
4.6 Middle East and Africa Herceptin (Trastuzumab) Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Herceptin (Trastuzumab) Sales Quantity by Type (2019-2030)
5.2 Global Herceptin (Trastuzumab) Consumption Value by Type (2019-2030)
5.3 Global Herceptin (Trastuzumab) Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Herceptin (Trastuzumab) Sales Quantity by Application (2019-2030)
6.2 Global Herceptin (Trastuzumab) Consumption Value by Application (2019-2030)
6.3 Global Herceptin (Trastuzumab) Average Price by Application (2019-2030)
7 North America
7.1 North America Herceptin (Trastuzumab) Sales Quantity by Type (2019-2030)
7.2 North America Herceptin (Trastuzumab) Sales Quantity by Application (2019-2030)
7.3 North America Herceptin (Trastuzumab) 麻豆原创 Size by Country
7.3.1 North America Herceptin (Trastuzumab) Sales Quantity by Country (2019-2030)
7.3.2 North America Herceptin (Trastuzumab) Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Herceptin (Trastuzumab) Sales Quantity by Type (2019-2030)
8.2 Europe Herceptin (Trastuzumab) Sales Quantity by Application (2019-2030)
8.3 Europe Herceptin (Trastuzumab) 麻豆原创 Size by Country
8.3.1 Europe Herceptin (Trastuzumab) Sales Quantity by Country (2019-2030)
8.3.2 Europe Herceptin (Trastuzumab) Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Herceptin (Trastuzumab) Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Herceptin (Trastuzumab) Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Herceptin (Trastuzumab) 麻豆原创 Size by Region
9.3.1 Asia-Pacific Herceptin (Trastuzumab) Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Herceptin (Trastuzumab) Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Herceptin (Trastuzumab) Sales Quantity by Type (2019-2030)
10.2 South America Herceptin (Trastuzumab) Sales Quantity by Application (2019-2030)
10.3 South America Herceptin (Trastuzumab) 麻豆原创 Size by Country
10.3.1 South America Herceptin (Trastuzumab) Sales Quantity by Country (2019-2030)
10.3.2 South America Herceptin (Trastuzumab) Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Herceptin (Trastuzumab) Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Herceptin (Trastuzumab) Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Herceptin (Trastuzumab) 麻豆原创 Size by Country
11.3.1 Middle East & Africa Herceptin (Trastuzumab) Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Herceptin (Trastuzumab) Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Herceptin (Trastuzumab) 麻豆原创 Drivers
12.2 Herceptin (Trastuzumab) 麻豆原创 Restraints
12.3 Herceptin (Trastuzumab) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Herceptin (Trastuzumab) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Herceptin (Trastuzumab)
13.3 Herceptin (Trastuzumab) Production Process
13.4 Herceptin (Trastuzumab) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Herceptin (Trastuzumab) Typical Distributors
14.3 Herceptin (Trastuzumab) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Roche Diagnostics
Genentech
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
Amgen
Samsung Bioepis
Merck
Mylan
Teva Pharmaceutical
Mundipharma
Mabion
AryoGen Biopharma
Genor Biopharma
听
听
*If Applicable.
